Title : Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study.

Pub. Date : 2021

PMID : 33679150

1 Functional Relationships(s)
Compound Name
Protein Name
1 In this study, we docked five clinically used drug molecules, favipiravir, hydroxychloroquine, remdesivir, lopinavir, and ritonavir onto three target proteins, the receptor-binding domain of SARS-CoV-2 spike protein, SARS-CoV-2 main protease, and human furin protease. Hydroxychloroquine surface glycoprotein Severe acute respiratory syndrome coronavirus 2